LifeMD, Inc. (LFMD) Misses Q2 EPS by 6c

LifeMD, Inc. (NASDAQ: LFMD) reported Q2 EPS of ($0.16), $0.06 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $49.15 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Klarna Group (KLAR) 46K contracts trade, share price down 21.5%
• Clean Energy Fuels (CLNE) PT Lowered to $2.50 at Raymond James